"Diabeton" ko "Manini" - cewa shi ne mafi alhẽri yi wa ciwon sukari?

Yawan ciwon sukari marasa lafiya a cikin 'yan shekaru ya karu ma. Miyagun halaye, matalauta rage cin abinci, rashin ingancin barci - duk abubuwan da kai ga ci gaban da cutar. An muhimmiyar rawa aka buga ta kayyade predisposition, kuma pancreatic cuta. Yana da wannan jiki ne ke da alhakin samar da insulin. Tare da kasa gland shine yake aiki na tasowa ciwon sukari. Insidious cuta bukatar ingantaccen da kuma m magani. A farkon matakai da cutar ne yadu used kwayoyi kamar "Diabeton" ko "Manin". Menene ya kamata na yi amfani? A yanke shawara ya kamata a karɓi tare da likita.

Drug "Diabeton"

Wannan hypoglycemic wakili, sulfonylurea wanda aka samu na biyu ƙarni. Tare da betakletok magani taimaka pancreas, don samar da insulin, qara ji na ƙwarai daga gefe kyallen takarda, rage tazarar lokaci daga lokacin da abinci kafin samar da insulin, sakamakon al'ada jijiyoyin bugun gini permeability.

Da miyagun ƙwayoyi yana antirogennym mataki, rage yi a total cholesterol. Kada ka ba magani wajen samar da mikrotrombozov da kuma atherosclerosis, daidai a jini wurare dabam dabam. Tare da ci gaban m nephropathy a bango na dogon yanke shawara gliklozidov rage-rage proteinuria. Saboda haka, masana sau da yawa rubũta a wajen "Manin" ko "Diabeton". Mene ne mafi alhẽri ga amfani a wani batu, likita yanke shawarar, bayan jerin gwaje-gwaje.

Pharmacokinetics

Da zarar a ciki yana nufin sauri raba. Matsakaicin sakamako ne kai bayan 4 hours bayan gwamnati. Fili jini gina jiki ne kusan 100%. A cikin hanta, da aiki bangaren suranta game 8 metabolites.

Excreted miyagun ƙwayoyi domin 12 hours mafi kodan. Ba fiye da 1% excreted a cikin fitsari a canzawa form. Wanne ne mafi alhẽri, "Diabeton" ko "Manin" kwayoyi dauki, m endocrinologist. Masana sun lura cewa kwayoyi da irin wannan illa da kan jiki.

Alamomi da kuma contraindications

Shiri "Diabeton" da aka nuna a cutar ciwon sukari Type II ciwon sukari, wanda shi ne maras insulin. Har ila yau, da miyagun ƙwayoyi An wajabta a matsayin prophylaxis a harka na take hakkin da microcirculation a hade tare da sauran jamiái.

Contraindications for lozenges ne ciwon sukari mellitus farko type, coma ko predkomovoe jihar. Kamata ba za a wajabta da miyagun ƙwayoyi a ketoacidosis, take hakkin kodan da kuma hanta. An ba da shawarar hada ci gliklozidov da imidazole Kalam. Hypersensitivity zuwa sulfonamides da sulfonylureas ake amfani da Allunan "Diabeton" ko "Mannino". Reviews nuna cewa rashin amfani da kwayoyi na iya haifar da illa.

sashi

Fara far da wani sashi na 80 MG. Daily kudi ba zai iya wuce 320 MG. Da miyagun ƙwayoyi ne riƙi sau biyu a rana bayan da abinci. A hanya na lura iya zama isasshe tsawon. The matakan dakatar far daukan wani likita bayan wani na sosai jarrabawa na haƙuri.

A wani asibiti yanayi, Allunan, "Diabeton" ko "Mannino". Yana da kyau a dauki a wani batu? Shirye-shirye ne analogues. A muhimmanci bambanci tsakanin su. Zabi nufin zai fi dacewa bayan shawara endocrinologist.

illa

Lokacin amfani da miyagun ƙwayoyi iya samun m bayyanar cututtuka irin su amai da tashin zuciya, ciki zafi. A rare lokuta na iya ci gaba leukopenia ko thrombocytopenia. Wasu marasa lafiya fuskanci wani rashin lafiyan dauki. Yana bayyana kanta a cikin irin kurji da itching. Lokacin da wani magani yawan abin sama na iya zama da qarancin ruwa da.

A lokacin far kamata a kai a kai aikata wani jini gwajin for glucose. Kada ku riƙi magani a tare da magunguna dauke da verapamil da cimetidine. Na nufin "Diabeton 'da kuma' Manina 'reviews na likitoci da a mafi kyau. Idan wadannan kwayoyi suna amfani daidai da umarnin, suka taimake su da muhimmanci inganta kiwon lafiya na marasa lafiya da ciwon sukari mellitus.

"Manin" kwaya

Wannan hypoglycemic wakili don baka amfani. Babban abu a cikin abun da ke ciki an dauke su kwayoyi glibenclamide. An kerarre a cikin nau'i na alluna da daban-daban dosages. Saki da miyagun ƙwayoyi a cikin wani filastik ganga. Kowane kunshin ƙunshi 120 Allunan.

Idan gwani yayi sayan samfurin "Manin" ko "Diabeton", shi ne mafi alhẽri amfani? Da shirye-shirye da irin wannan effects. A yanke shawara ya kamata a dauka bayan nazarin umarnin don amfani da kwayoyi.

Action nufin "Manin"

Da miyagun ƙwayoyi nasa ne da rukuni na sulfonylurea 2 tsara. Yana yana a kan hypoglycemic mataki. Betakletkam taimaka pancreas, don samar da insulin. Insulin fara yi nan da nan bayan da abinci. Hypoglycemic sakamako dõge ga kwana.

Saboda haka abin da za a zabi - kwayoyi "Diabeton" ko "Manin"? Wanne magani ne mafi alhẽri ga sauƙaƙe haƙuri da yanayin? A yanke shawara za ta dauki likita, bayan jerin gwaje-gwaje.

Alamomi da kuma contraindications

The alamomi ga yin amfani da shiri "Mannino" An dauke da wani biyu irin ciwon sukari. An yarda a kan wani mutum-akai ko a hade tare da sauran hypoglycemic kwayoyi. Ba za ka iya sanya wakili a cikin hali na hypersensitivity da aka gyara na da Allunan.

Magani ne contraindicated ga marasa lafiya da ciwon sukari na farko da irin. An ba da shawarar a yi amfani da samfurin bayan tiyata a kan pancreas. Tã kwarara koda ko hanta hanawa ne ma dalilin da ya haramta yin amfani da Allunan 'Diabeton "ko" Manin ". Yana da kyau a dauki idan akwai contraindications, gaya da gwani. Kai-magani ba daraja yi.

sashi

Sashi dogara da tsanani da cuta, kazalika da Manuniya na glucose a cikin haƙuri na jini. A can farko dole dauki wani fiye da alluna biyu a kowace rana. Don kauce wa qarancin ruwa a tsofaffi da marasa lafiya wajabta da miyagun ƙwayoyi a rage yawan kashi.

Da irin wannan illa da kan jiki "Diabeton" kwayoyi da kuma "Manin". Kwatanta sa ya bayyana a fili cewa kwayoyi za a iya amfani da a wannan bayyanar cututtuka. Contraindications da kuma m events ma ba su sãɓã ba.

"Diabeton" ko "Manini" - wanda shi ne mafi alhẽri?

Wanda ke nufin fita domin lura da ciwon sukari, endocrinology kamata yanke shawara akayi daban-daban. Dole ne mu yi la'akari da mutum halaye da kwayoyin.

Yana dole ne a tuna da cewa kwayoyi ne daban-daban a cikin abun da ke ciki. Kulawa da zabi na da miyagun ƙwayoyi kamata a bai wa mutanen da suke yiwuwa ga rashin lafiyan halayen.